Powering Innovation that Drives Human Advancement

Cardiovascular Symposium - Spring 2025

Please join Ansys on Thursday, April 3rd at 10:00 AM EDT for the virtual Cardiovascular Symposium. This free event is primarily for decision-makers but it is open to anyone involved in silico cardiovascular applications.

To encourage collaboration in research and, therefore, increase the efficiency of our in silico cardiovascular community, Ansys coordinates an in silico cardiovascular ecosystem.

Together we are defining, and continuously refining, a clear vision of how in silico methods and digital twins can assist the cardiovascular community in developing more impactful models.

Watch Presentation

First Name *

Last Name *

Company or School *

Are You a Student? *

Email Address *

Phone

Country/Region *

City *

Postal Code *

Job Level

By providing your information, you agree to these Terms and to the processing of your personal data for the purposes of providing the activity and for related communications, including cross-border transfers (i.e., Ansys is a global company) and inter-company and third party sharing, as detailed in the Privacy Notice.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OVERVIEW

AGENDA

SPEAKERS

Fighting Cardiovascular Diseases with in silico Solutions

Computational modeling and simulation (CM&S) of cardiovascular devices and their working environment — the human body and heart — is the most promising way to accelerate and amplify medical innovation while limiting the risk for the patients through in silico research, in silico testing, and in silico clinical trials.

Our simulations go beyond an advanced cardiovascular system model by using multiscale, multiphysics simulations in a suite of connected tools to provide a complete and pragmatic solution.

Agenda

TIME (EDT)	TOPIC	PRESENTER
10:00 AM - 10:05 AM	Introduction	Thierry Marchal, Program Director & Chief Technologist EMEA Healthcare, Ansys
10:05 AM - 10:20 AM	In Silico Cardiovascular Vision and Ecosystem	Mark Palmer, Field CTO Healthcare, Lead Chief Technologist, Ansys
10:20 AM - 10:40 AM	Bridging virtual twins and clinical needs: A 300-patient study on left atrial appendage closure	Jordi Mill, Ph.D / Prof. Oscar Camara, Universitat Pompeu Fabra
10:40 AM - 11:00 AM	Computational Hemodynamics, Mechanical Biocompatibility, and Future of Personalized Medicine	Dr. Farhad R. Nezami, Brigham & Women Hospital, Harvard Medical School
11:00 AM - 11:20 AM	Accelerating cardiovascular pre-operative planning and building large cohort of patient realistic modeling: the mesh morphing solution	Prof. Marco Biancolini, Founder RBF Morph
11:20 AM - 11:55 AM	Brainstorming - Shaping the Future of In Silico Cardiovascular	Marc Horner, Distinguished Engineer, Ansys
11:55 AM - 12:00 PM	Wrap Up & Next Meeting	Thierry Marchal, Program Director & Chief Technologist EMEA Healthcare, Ansys

Back to top

Speakers

Prof Marco Evangelos Biancolini

Founder at RBF Morph

Marco Evangelos Biancolini is an Associate Professor of Machine Design at the University of Rome Tor Vergata. His primary research interests lie in the engineering applications of fast radial basis functions, mesh morphing, and their use in the field of shape optimization, as well as reduced order models for the definition of digital twins. He is the owner and developer of the industrial software RBF Morph, a partner of Ansys, and a member of the Technet Alliance. Since 2020, Dr. Biancolini has served as the principal investigator of the 4-year ITN-EID H2020 project “Medical Digital Twins for Aneurysm Prevention and Treatment” (MeDiTATe).

Dr. Farhad R. Nezami

Professor Brigham & Women Hospital, Harvard Medical School

Dr. Farhad R. Nezami currently serves as the Lead Investigator at the Division of Cardiac Surgery at Mass General Brigham, holds the position of Assistant Professor at Harvard Medical School, and is an affiliate Faculty member at the Institute for Medical Engineering and Science at MIT. With a PhD in Mechanical Engineering from ETH Zurich, Dr. Nezami's diverse research portfolio spans human pathophysiology, translating preclinical experiments to clinical practices, optimizing medical device design, and pioneering engineering platforms that bridge the gap from laboratory bench and computational toolkit to the patient's bedside.

Professor Oscar Camara

Professor at Universitat Pompeu Fabra

Dr. Oscar Camara is a Full Professor and Director of the Engineering School at Universitat Pompeu Fabra (UPF) in Barcelona, Spain. He earned his Telecommunications Engineering degree from Universitat Politècnica de Catalunya in 1999 and subsequently obtained a Master's and Ph.D. in Image Processing from Télécom Paris in 2000 and 2003, respectively. Following his doctoral studies, Dr. Camara conducted postdoctoral research at King's College London and University College London between 2004 and 2007. In 2007, he joined UPF as a "Ramón y Cajal" Fellow and later founded the PhySense research group in 2011, focusing on methodologies that integrate computational imaging and modeling for clinical applications across oncology, neurology, and cardiology.